S 5571
  • Introduced
    Sep 28, 2026
  • Passed Senate
  • Passed House
  • Became Law
S 5571
United States Senate Bill
Did you know we offer free bill tracking in Congress and 50 states, AI tools to streamline your work, and a great mobile app? Sign up here
A bill to amend title XI of the Social Security Act to alter when biosimilar biological products are eligible for price negotiations under the Medicare program.
Last Action See all actions
Senate • Sep 28, 2026: Read twice and referred to the Committee on Finance.

Summary

Comments on S 5571

Tweets

Whip Lists

Sponsors
Votes
Looks like there aren't any voting records available at this moment.
Actions
  • Sep 28, 2026 | Senate
    • Introduced in Senate
    • Read twice and referred to the Committee on Finance.
Bill Texts
Looks like there aren't any bill texts available at this moment.
Documents
Looks like we don't have any documents available at this moment.
Sources